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Abstract: Two adipokines (adiponectin and resistin) have opposite relations with insulin resistance
and inflammation. Our major focus was to determine whether there were detectable ethnic
differences in maternal adipokines during pregnancy. We also explored the correlation of the
adipokines with maternal glucose homeostasis, blood pressure and anthropometric parameters.
Pregnant women (n = 1634) were from a large prospective cohort study in Camden NJ
(African-American 36.8%; Hispanic 47.6%; Caucasian 15.6%). Serum adiponectin and resistin
were measured at entry (week 16.8) and the 3rd trimester (week 30.7) using the Luminex
xMapTechnology. Significant differences were observed among ethnic groups, controlling for
confounding variables. African American women were exceptional in that they had decreased
adiponectin and increased resistin throughout the course of pregnancy (p < 0.05 to p < 0.0001) and
a greater than two fold risk of simultaneously exhibiting low adiponectin (lowest tertile) and high
resistin (highest tertile) compared to Caucasians and/or Hispanics. The cohort as a whole and each
ethnic group showed similar negative correlations between adiponectin, and glucose homeostasis,
blood pressure and anthropometric parameters but there was lesser correspondence with resistin.
Our data underscore the need for further research on ethnic variation in adipokines and other
physiologic biomarkers during complicated and uncomplicated pregnancy.
Keywords: ethnic difference; adipokine; adiponectin; resistin; normal pregnancy; anthropometric
parameters; glucose homeostasis; blood pressure

1. Introduction
Adiponectin and resistin are hormones that are produced and secreted exclusively by the
adipocyte [1,2]. The two hormones have opposite relations with insulin resistance—a mechanism
that underlies many conditions including the development of cardiovascular disease (CVD) [3–5].
Plasma adiponectin is a strong anti-inflammatory marker whereas plasma resistin is positively related
to inflammation and insulin resistance [2–4,6].
While ethnic differences in the body composition, insulin resistance and metabolic syndrome
are well known [7–9]; the fundamental reason for these differences is not. It is also unclear if
dissimilarities in glucose, lipids and inflammation contribute to the ethnic disparity in chronic
disease [10–13]. While some studies suggest that adiponectin and resistin may be involved in
serious complications of pregnancy where disparities also exist—such as gestational diabetes mellitus
(GDM) and preeclampsia [14–17], underlying ethnic variability has not been described in pregnant
women. Thus, the purpose of this study was to prospectively investigate ethnic variation in maternal
adiponectin and resistin levels during normal pregnancy. We used data from a large cohort that
included pregnant Hispanic, African American and Caucasian women. We also examined, by
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ethnicity, the associations of the two adipokines with maternal anthropometry, blood pressure and
glucose homeostasis during early and late gestation.
2. Materials and Methods
2.1. Study Design and Ethics Statement
We conducted a prospective epidemiological study of young, generally healthy pregnant women
residing in one of the poorest cities in the continental United States [18]. The cohort of study
participants enrolled between 1996 and 2006 was recruited from among patients enrolling at the
Osborn Family Health Center, Our Lady of Lourdes Medical Center and St John the Baptist prenatal
clinic in Camden, NJ. The institutional review board at the University of Medicine and Dentistry of
New Jersey (which later became Rowan University School of Osteopathic Medicine in 2013) approved
the study protocol. Informed written consent was obtained from each participant at enrollment (on
average at gestational week 13.48  5.18, mean  SD) after explanation of the nature and purpose of
the study.
2.2. Subjects
A total of 3.5% of the women who were screened had serious non-obstetric problems (e.g., lupus,
type 1 or 2 diabetes, seizure disorders, malignancies, acute or chronic liver disease, drug or alcohol
abuse and psychiatric problems) were not eligible. Eighty percent of the patients who were eligible
agreed to participate. A total of 8.3% of participants dropped out after enrollment due either to a
move from the area or to an early pregnancy loss. A final total of 1634 participants with specimens
collected at entry and the 3rd trimester were included to this analysis.
2.3. Data and Blood Sample Collection
Participants were scheduled to see study research assistants before or after their regular prenatal
visits at entry, gestational weeks 20 and 28. Data on socioeconomic, demographic and lifestyle were
obtained by interview at entry to care and updated at gestational weeks 20 and 28. Interview data,
dietary data and anthropometrics were collected in person by research assistants at these three times.
Ethnicity was self-defined. Blood pressure was measured by clinic staff at each visit and
abstracted from the medical records. Body mass index (BMI) (kg/m2 ) was computed based on
self-reported pregravid weight; height was measured at entry to prenatal care. Maternal obesity
was defined as BMI ¥ 30. Skinfold thickness was measured by a skinfold caliper (Cambridge
Scientific Industries, Inc., Cambridge, MA) and upper arm fat was computed with measures of arm
circumference and triceps thickness as described [19]. Three different points of the skinfold thickness
including triceps, subscapular and suprailiac were totaled.
Fasting blood samples (>8 h) were drawn at entry (gestational weeks 16.85  5.46, mean  SD)
and during the 3rd trimester (gestational weeks 30.74  3.58). A standardized protocol for biological
specimen collection is used for the Camden Study which includes the serum preparation used in the
current study. The serum was immediately transferred into clean polypropylene cryovials and stored
at –80  C. The serum samples were aliquoted and not thawed until assayed.
2.4. Analytic Procedures
2.4.1. Adipokine Assay
Adiponectin and resistin concentrations were analyzed on the Magpix system using the Luminex
xMAP technology (Luminex Corporation, Austin, TX, USA). Serum concentrations of adiponectin
and resistin were determined simultaneously by the human adipokine 2-plex magnetic bead panel
from EMD Millipore Corporation (HADK1MAG-61K-2, Billerica, MA, USA). According to the
manufacturer, there was no or negligible cross-reactivity between the antibodies for an analyte and
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any of the other analytes in this panel. The minimal detectable concentrations were 11 pg/mL
for adiponectin and 2.2 pg/mL for resistin. The coefficient variations within and between assays
was 4.4% and 10.1% for adiponectin and 5.5% and 11.3% for resistin. All analyses were performed
according to the manufactures’ protocols and done in duplicate. The concentrations were calculated
from best-fit standard curves generated from calibrators for each analyte in each assay.
2.4.2. Glucose Homeostasis Measures
Fasting plasma glucose was measured with the glucose oxidase method (glucose reagent from
Sigma Diagnostics, St. Louis, MO, USA) on a spectrophotometer at a wavelength of 505 nm.
Serum insulin was determined by radioimmunoassay (RIA) using a kit with a specific antibody
that crossreacts only minimally (<0.2%) with proinsulin and has a high sensitivity (2 µµU/mL or
12 pmol/L). Plasma C-peptide was determined by an RIA kit with high sensitivity (0.1 ng/ml or
0.033 nmol/l) and low crossactivity to proinsulin (<4%) (Linco, St. Charles, MO, USA). The coefficient
of variation within and between assays was 3.2% and 6.3% for C-peptide, 3.5% and 6.5% for insulin,
1.5% and 3.0% for glucose. The homeostasis model of assessment for insulin resistance (HOMA-IR)
was computed from the same day’s fasting specimens of glucose and insulin divided by a constant
(22.5), under the assumption that young normal subjects have an insulin resistance of 1.0 [20–22].
2.5. Statistical Analysis
Maternal characteristics among ethnic groups were compared by ANOVA (for continuous
variables) and x2 tests (for categorical variables). ANOVA was used to assess the significance of linear
trend and compare mean levels of each adipokine among ethnic groups after controlling for potential
confounding variables. The Bonferroni procedure was used to correct for multiple comparisons.
We divided each adipokine into tertiles and used multiple logistic regression analysis to estimate
the Odds Ratio (OR) and 95% confidence interval (CIs) for the likelihood of decreased adiponectin
(the lowest tertile) and increased resistin (the highest tertile) with ethnicity. Separate models were
performed to examine differences in adipokine levels at entry to care and in the 3rd trimester among
ethnic groups.
The relationship between adipokine levels with glucose homeostasis as well as anthropometric
parameters was assessed by computing Pearson’s r for all women as well as for each ethnic group.
The relation for these same parameters with low adiponectin (lowest tertile) combined with high
resistin (highest tertile) was assessed by a point biserial correlation (r pb ). Multivariable models were
controlled for potential confounding variables including maternal BMI, age, parity, and cigarette
smoking. Potential confounders were defined as those which altered the adjusted odds ratio or
regression coefficient by at least 10%, and assessed by comparing crude and adjusted coefficients.
The statistical significant level was defined as p < 0.05. All statistical analyses were performed
using SAS v.9.2 (SAS Institute, Inc., Cary, NC, USA).
3. Results and Discussion
Selected characteristics of study participants are shown in Table 1. African-American women
were younger and had higher pre-pregnant BMI comparing to Caucasian or Hispanic women, and
Caucasians were about twice as likely to smoke as other gravidas. Other variables including obesity,
the sum of skinfolds, and blood pressure were comparable among African American, Hispanic and
Caucasian women.
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Table 1. Characteristics of study participants at entry by ethnicity a .
Characteristics
b

Age (year.)
Pre-pregnant BMI (kg/m2 ) c
Obese (BMI 30)
Sum of skinfolds (mm)
Upper arm fat area (mm)
SBP (mmHg)
DBP (mmHg)
Nulliparous
Cigarette smoking b

¥

All Subjects

African American (n = 602)

Hispanic (n = 777)

Caucasian (n = 255)

22.03 5.29
25.73 6.30
329 (20.13)
70.62 29.56
28.40 16.24
112.20 11.35
70.21 8.66
640 (39.17)
310 (18.97)

21.38 5.02
26.15 7.01
135 (22.43)
72.19 32.45
29.74 18.75
113.81 11.65
71.21 9.07
225 (37.38)
117 (19.44)

22.19 5.27
25.74 5.88
148 (19.05)
70.33 28.05
27.59 14.80
110.78 10.90
69.56 8.18
311 (40.03)
95 (12.23)

23.11 5.75
24.72 5.65
46 (18.04)
67.95 26.69
27.69 13.79
112.74 11.49
69.84 8.91
104 (40.78)
98 (38.43)





























SBP, systolic blood pressure; DBP, diastolic blood pressure; a Data are mean  SD or n (%). Twelve Asian
women are included in the Caucasian group; b p for trend <0.0001; c p for trend <0.01.

3.1. Comparison of Adipokines among Ethnic Groups
Adiponectin concentration decreased between entry and the 3rd trimester in all women from the
cohort as well as for each ethnic group (p < 0.0001 for each) whereas resistin concentrations remained
unchanged (p > 0.05 for each).
Significant differences in serum concentrations of adiponectin and resistin were observed
among ethnic groups after controlling for several confounding variables including pre-pregnant BMI
(Table 2). A graded pattern of adiponectin was obtained where African American women had the
lowest adiponectin level compared to Hispanic and/or Caucasians both at entry and during the 3rd
trimester. The difference between Hispanic and Caucasian women was also significant (p < 0.05) with
Hispanics having lower concentrations.
Table 2. Difference in adiponectin and resistin concentrations by ethnicity a .
Ethnic Group
All subjects
African American
Hispanic
Caucasian

Adiponectin (µg/mL)
Entry
3rd Trimester
17.66  0.21
16.49  0.36 b,c
17.90  0.32 d
19.34  0.57

14.75  0.20
13.23  0.29 b,e
15.16  0.33 d
16.72  0.52

Resistin (ng/mL)
Entry
3rd Trimester
47.49  0.63
50.32  1.10 e
45.28 1.11 d
49.43  1.73

48.22  0.62
50.35  1.09 c
46.61  0.96
49.24  1.72

Data are mean  SE. Models were adjusted for maternal age, pre-pregnancy BMI, parity and cigarette
smoking; b p < 0.0001 vs. Caucasian; c p < 0.01 vs. Hispanic; d p < 0.05 vs. Caucasian; e p < 0.0001 vs. Hispanic.
a

A different pattern was shown for resistin. Hispanics had the lowest resistin level and African
American women had the highest (p < 0.0001 at entry and p < 0.01 at 3rd trimester vs. Hispanics).
While levels in African Americans did not differ significantly from levels in Caucasians, entry levels
in Hispanics were significantly lower than Caucasians.
3.2. Association of Ethnicity with Low Adiponectin (Lowest Tertile) and High Resistin (Highest Tertile)
After control for potential confounding variables and using Caucasians as reference (Table 3),
African American women were twice as likely to have low adiponectin (lowest tertile) at entry and
in the 3rd trimester. The results did not change significantly after controlling for pre-pregnant BMI
(model 2). Although Hispanics had lower adiponectin than Caucasians (Table 2), their likelihood of
being in the lowest tertile was not significant except during the 3rd trimester and only when BMI
was not controlled (adjusted odds ratio (AOR) 1.43, 95% confidence interval (CI) 1.02, 2.00, Table 3,
model 1).
The results were not statistically significant when testing for ethnic differences in increased
resistin (highest tertile) using the Caucasians as the reference group. Because the distribution of
resistin among ethnic groups was different from adiponectin, in that Hispanics had the lowest resistin
level, we analyzed data by using Hispanics as reference (Table 4). African American women were
more likely to be in the highest resistin tertile compared to Hispanics both at entry and in the 3rd
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trimester when models were fully controlled (AOR 1.47, 95% CI 1.17, 1.85 for entry; AOR 1.29,
95% CI 1.03, 1.62 for 3rd trimester, Table 4, model 2). The adjusted odds ratios were not significant
comparing Caucasians to Hispanics.
Table 3. Multiple logistic regression analysis for the associations of decreased adiponectin with ethnicity.
Low Adiponectin a
Entry
African American
Hispanic
Caucasian
3rd Trimester
African American
Hispanic
Caucasian

Unadjusted n (%)

AOR (95% CI) Model 1 b

AOR (95% CI) Model 2 c

248 (41.2)
235 (30.24)
66 (25.88)

2.07 (1.48, 2.89)
1.23 (0.90, 1.74)
Reference

1.86 (1.32, 2.63)
1.15 (0.82, 1.61)
Reference

258 (42.86)
230 (29.60)
59 (23.14)

2.61 (1.85, 3.66)
1.43 (1.02, 2.00)
Reference

2.41 (1.70, 3.41)
1.34 (0.95, 1.89)
Reference

AOR, adjusted odds ratio; 95% CI, 95% confidence interval, same in Tables 4 and 5; a Low adiponectin was
defined as the lowest tertile (¤12.85 µg/mL at entry and ¤10.35 µg/mL at 3rd trimester) as compared to
tertiles one and two pooled; b Model 1: Adjusted for age, parity and cigarette smoking; c Model 2: Additional
adjustment for pre-pregnant BMI.

Table 4. Multiple logistic regression analysis for the associations of elevated resistin with ethnicity.
High Resistin a
Entry
African American
Hispanic
Caucasian
3rd Trimester
African American
Hispanic
Caucasian

Unadjusted n (%)

AOR (95% CI) Model 1 b

AOR (95% CI) Model 2 c

227 (37.71)
228 (29.34)
91 (35.64)

1.49 (1.18, 1.87)
Reference
1.18 (0.87, 1.61)

1.47 (1.17, 1.85)
Reference
1.21 (0.89, 1.65)

219 (36.38)
233 (29.99)
94 (36.86)

1.31 (1.04, 1.65)
Reference
1.24 (0.91, 1.69)

1.29 (1.03, 1.62)
Reference
1.28 (0.94, 1.74)

a High resistin was defined as the highest tertile (¥52 ng/mL at entry and ¥53 ng/mL at 3rd trimester)
compared to tertiles one and two pooled; b Models were adjusted for age, parity and cigarette smoking;
c Additional adjustment for pre-pregnant BMI.

Seventy three women developed GDM during late pregnancy (n = 12, 42, 19 for African
American, Hispanics and Caucasians, respectively). After excluding women who developed GDM
during the 3rd trimester, these results again remained unchanged. For example, the AOR was 2.64
for model 1 (95% CI 1.82, 3.84) and was 2.43 for model 2 (95% CI 1.67, 3.55) in African Americans
compared to Caucasians (Table 3).
In addition, African Americans appeared to have a unique difference in that they had an
increased risk of simultaneously having both low adiponectin and high resistin throughout the course
of pregnancy compared to Caucasians (AOR 2.23, 95% CI 1.28, 3.87 at entry and AOR 1.70, 95% CI
1.01, 2.89 for the 3rd trimester, Table 5, model 2) as well as compared to Hispanics (AOR 2.19, 95% CI
1.52, 3.17 at entry and AOR 1.83, 95% CI 1.27, 2.63, Table 6, model 2).
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Table 5. Association of combination of low adiponectin and high resistin with ethnicity a .
Ethnic Group
Entry
African American
Hispanic
Caucasian
3rd trimester
African American
Hispanic
Caucasian

Unadjusted

AOR (95% CI)

n (%)
87 (14.45)
55 (7.08)
18 (7.06)

Model 1
2.55 (1.48, 4.39)
1.09 (0.62, 1.92)
Reference

Model 2 c
2.23 (1.28, 3.87)
1.02 (0.57, 1.80)
Reference

80 (13.29)
58 (7.46)
20 (7.84)

1.89 (1.12, 3.19)
1.00 (0.58, 1.72)
Reference

1.70 (1.01, 2.89)
0.93 (0.54, 1.61)
Reference

b

The lowest tertile of adiponectin (¤12.85 µg/mL for entry and ¤10.35 µg/mL for 3rd trimester) and the
highest tertile of resistin (¥52 ng/mL for entry and ¥53 ng/mL for 3rd trimester) were combined vs. other
tertiles, using Caucasians as reference; b Model 1: Adjusted for age, parity and cigarette smoking; c Model 2:
Additionally adjustment for pre-pregnant BMI.

a

Table 6. Association of combination of low adiponectin and high resistin with ethnicity a .
Ethnic Group
Entry
African American
Hispanic
Caucasian
3rd trimester
African American
Hispanic
Caucasian

Unadjusted

AOR (95% CI)

n (%)
87 (14.45)
55 (7.08)
18 (7.06)

Model 1
2.34 (1.63, 3.36)
Reference
0.92 (0.52, 1.62)

Model 2 c
2.19 (1.52, 3.17)
Reference
0.98 (0.56, 1.74)

80 (13.29)
58 (7.46)
20 (7.84)

1.89 (1.31, 2.71)
Reference
1.00 (0.58, 1.72)

1.83 (1.27, 2.63)
Reference
1.07 (0.62, 1.86)

b

The lowest tertile of adiponectin (¤12.85 µg/mL for entry and ¤10.35 µg/mL for 3rd trimester) and the
highest tertile of resistin (¥52 ng/mL for entry and ¥53 ng/mL for 3rd trimester) were combined vs. other
tertiles, using Hispanics as reference; b Model 1: Adjusted for age, parity and cigarette smoking; c Model 2:
Additionally adjustm ent for pre-pregnant BMI.

a

3.3. The Correlation between Adipokine Levels with Maternal Factors
Finally, adiponectin concentrations were significantly and negatively correlated with maternal
BMI, sum of skinfolds, arm fat area, systolic and diastolic blood pressure and, glucose homeostasis
parameters (fasting glucose, insulin, C-peptide and HOMA-IR) at entry (Figure 1A, p < 0.05 to
p < 0.0001 for r = 0.11 to r = 0.30) and during the 3rd trimester (Figure 1B, p < 0.05 to p < 0.0001,
r = 0.10 to r = 0.27). A similar relationship was observed for each of the ethnic groups.
Shown are Pearson correlation coefficients in all women and by ethnicity. For fasting glucose,
insulin and C-peptide (n = 1323).
SBP, systolic blood pressure; DBP, diastolic blood pressure; Sum SKF, sum of skinfolds; Arm fat,
upper arm fat area; HOMA-IR, the homeostatic model assessment of insulin resistance (same as in
Figures 2 and 3).
A

B

Negative correlation between adiponectin concentration with selected parameters at entry:
p < 0.05 to p < 0.0001 for each of parameters tested in all women, Hispanics and African
Americans. In Caucasians, p < 0.05 to p < 0.001 with BMI, sum of skinfolds, arm fat area and
insulin; but p > 0.05 for SBP, DBP, C-peptide, glucose and HOMA-IR.
Negative correlation between adiponectin concentration with selected parameters during the
3rd trimester: p < 0.05 to p < 0.0001 for each of parameters tested in all women, Hispanics,
African Americans and Caucasians, except for DBP, fasting glucose in Hispanics (p > 0.05) and
DBP, glucose and HOMA-IR in Caucasians (p > 0.05).
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Figure 1. (A, at entry; B, during the 3rd trimester). The relationship between serum adiponectin
Figure
1. (A, at entry; B, during the 3rd trimester). The relationship between serum
(µg/mL) with anthropometric and glycemic parameters.
adiponectin (µg/mL) with anthropometric and glycemic parameters.

In contrast, the relationship between resistin and the same parameters was weaker and less

SBP,
systolic
blood2).pressure;
diastolicfasting
blood glucose
pressure;
SKF,blood
sum pressure
of skinfolds;
Arm fat,
consistent
(Figure
At entry,DBP,
in all subjects,
andSum
diastolic
were not
uppersignificantly
arm fat area;
HOMA-IR,
the homeostatic
model
assessment
of insulin
(same as in
correlated
with resistin
while SBP, BMI,
sum of
skinfolds, arm
fat area,resistance
fasting C-peptide,
insulin
and
HOMA-IR
were
modestly
related
(p
<
0.05
to
p
<
0.0001,
r
=
+0.07
to
r
=
+0.15
(Figure
2A).
Figures 2 and 3).
The pattern of correlation was similar but much weaker when examined by ethnicity. During the

A.3rdNegative
between were
adiponectin
selectedandparameters
at entry:
trimester, correlation
significant correlations
obtainedconcentration
between resistinwith
and systolic
diastolic blood
pressure,
sumtoof pskinfolds,
arm
area of
andparameters
BMI in all women
(p <
to p < Hispanics
0.001, r = +0.08
p < 0.05
< 0.0001
forfateach
tested in
all0.05
women,
and to
African
r = +0.20). A similar pattern was observed in Hispanics and Caucasians. In African American women,
Americans. In Caucasians, p < 0.05 to p < 0.001 with BMI, sum of skinfolds, arm fat area and
resistin was correlated only with the sum of skinfolds (r = +0.12, p < 0.01). None of the glucose
insulin; but
p > 0.05reached
for SBP,
DBP, C-peptide,
and
homeostasis
parameters
statistical
significanceglucose
overall or
byHOMA-IR.
ethnic groups (Figure 2B).
B. Negative correlation between adiponectin concentration with selected parameters during the
3rd trimester: p < 0.05 to p < 0.0001 for each of parameters tested in all women, Hispanics,

and diastolic blood pressure, sum of skinfolds, arm fat area and BMI in all women (p < 0.05 to
p < 0.001, r = +0.08 to r = +0.20). A similar pattern was observed in Hispanics and Caucasians. In
African American women, resistin was correlated only with the sum of skinfolds (r = +0.12, p < 0.01).
None Int.
of J.the
glucose homeostasis parameters reached statistical significance overall or by ethnic
groups
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(Figure 2B).

Figure 2. (A, at entry; B, during the 3rd trimester). The relationship between serum resistin (ng/mL)
Figure
2. (A, at entry; B, during the 3rd trimester). The relationship between serum resistin
with anthropometric and glycemic parameters.
(ng/mL) with anthropometric and glycemic parameters.

Shown are Pearson correlation coefficients in all women and by ethnicity.
A

B

The positive correlation between resistin concentration with selected parameters at entry:
p < 0.05 to p < 0.0001 for each parameter tested in all women, Hispanics and Caucasians, except
for DBP, fasting glucose in all women and Hispanics (p > 0.05); for SBP, DBP, BMI and fasting
glucose in Caucasians (p > 0.05). The correlations were all non-significant in African Americans
except for sum of skinfolds (p < 0.01).
The positive correlation between resistin concentration with selected parameters at the 3rd
trimester: p < 0.05 to p < 0.0001 for SBP, DBP, BMI, sum of skinfolds and arm fat area in all
women and Hispanics; p < 0.01 for sum of skinfolds in African Americans; p < 0.001 and p < 0.05
for sum of skinfolds and arm fat area in Caucasians. Other parameters were all non-significant.

The correlation between the same parameters with the combination of low adiponectin and
high resistin (Figure 3) was consistently positive and observed in all women (p < 0.05 to p < 0.0001,
r pb = +0.07 to r pb = +0.37) as well as by maternal ethnicity.

all non-significant.

The correlation between the same parameters with the combination of low adiponectin and hig
sistin (Figure 3) was consistently positive and observed in all women (p < 0.05 to p < 0.000
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Figure 3.

(A, at entry; B, during the 3rd trimester).

The relationship of variable combined

Figure 3. (A,
entry; B,(lowest
during
thewith
3rdhigh
trimester).
The tertile)
relationship
of variable
combined
lowatadiponectin
tertile)
resistin (highest
to anthropometric
and
glycemic parameters.
low adiponectin (lowest tertile) with high resistin (highest tertile) to anthropometric and
Shown are point biserial correlation (r pb ) coefficients in all women and by ethnicity.
glycemic parameters.
A
B

The positive correlation at entry: p < 0.05 to p < 0.0001 for each of parameters except fasting
glucose in Hispanics (p > 0.05) and DBP, fasting glucose and C-peptide in Caucasians (p > 0.05).
The positive correlation at the 3rd trimester: p < 0.05 to p < 0.0001 for each of parameters with
the exception of DBP, fasting glucose and insulin in Hispanics (p > 0.05), DBP and arm fat area
in African Americans (p > 0.05) and fasting glucose in Caucasians (p > 0.05).
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3.4. Discussion
Our study is unique in that we examined the relation of ethnic variation in two adipokines
with multiple parameters of maternal glucose homeostasis, blood pressure and with several
anthropometric measures taken in early and later pregnancy. We used data from a large prospective
cohort of 1634 normal pregnant women. We found that African American women had decreased
adiponectin and increased resistin levels during early and late gestation. Hispanics also had
decreased adiponectin, but their resistin levels were lower than African Americans (at both time
points) and Caucasians (at entry alone). Thus, African Americans were found to have a higher
prevalence of an exceptional pattern of adipokines that coupled low adiponectin with high resistin
throughout the course of pregnancy.
While ethnic differences in adiponectin have infrequently been reported during pregnancy they
have been described in non-pregnant subjects. Smith et al. found that healthy African American
women had lower adiponectin (p < 0.01) accompanied by reduced expression of several genes
involved in adipose tissue adipogenesis and lipogenesis when compared to Caucasians [23]. Lower
adiponectin concentrations have also been reported in South Asians and Aboriginal Canadians
compared to Europeans or Caucasians [24,25]. Findings from one of these studies (albeit in males
and non-pregnant females) of low adiponectin with increased insulin resistance is similar to what is
found in the pregnant state [25].
In an earlier case-control study, we described lower adiponectin among pregnant African
Americans regardless of whether they developed GDM, had hyperglycemia without overt GDM
or were normal controls; the difference was especially detectable during 3rd trimester [14]. In this
larger prospective cohort, we confirmed that African American women had significantly decreased
mean levels of adiponectin (versus Hispanics or Caucasians) and a two-fold increase of being in the
lowest tertile (vs. Caucasians) (Tables 2 and 3). These results were independent of several potential
confounding variables including BMI. To our knowledge, the current study is the first large scale and
prospective demonstration of ethnic differences in serum adiponectin for US pregnant women.
Likewise data describing ethnic differences in resistin during pregnancy are uncommon. The
only report of which we are aware showed no ethnic differences in resistin and other inflammatory
cytokines including TNF-α and C-reactive protein in non-pregnant Aboriginals compared to white
Canadians [24].
Among postmenopausal women and other subjects, elevated serum resistin is associated with
increased risk of type 2 diabetes, metabolic syndrome and ischemic stroke [3–6], but results from
pregnancy are conflicting. Small scale studies conducted late in gestation, usually following a
diagnosis of gestational diabetes, found resistin to be increased, decreased or unchanged compared
to controls [26–28]. As far as we are aware, no other investigators have reported the pattern we
detected among African Americans: An increased prevalence in the simultaneous combination of
low adiponectin with high resistin.
In the current study, adiponectin was significantly and negatively correlated at both time points
with all maternal factors examined including BMI, skinfolds, systolic and diastolic blood pressure,
fasting levels of glucose, insulin, C-peptide and HOMA-IR (Figure 1). When examined by ethnicity,
each group showed a similar correspondence between maternal factors and adiponectin.
Apart from positive correlations between resistin and maternal adiposity the association
between resistin and the same maternal factors was weak and inconsistent (Figure 2). No significant
correlation was observed between resistin and glucose homeostasis variables during the 3rd trimester
for any of the three ethnic groups. Likewise, the Hyperglycemia and Adverse Pregnancy Outcome
study showed that resistin was positively related to maternal BMI but not with fasting or 1 or 2 h
glucose [29]. Thus, maternal resistin concentration in non-GDM pregnancy may reflect adipose
or fat mass. The role of resistin in normal pregnancy, a condition with dramatic changes in
metabolic demand and cardiovascular function, remains poorly defined when compared to the
non-pregnant state.
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Several studies, none from pregnant women, have shown that ethnic differences in adiponectin
parallel ethnic variation in risk factors for CVD such as visceral fat distribution and insulin
resistance [10,24,25]. Since adiponectin is protective against inflammation and anthogenesis [1,5,7],
we hypothesize that decreased adiponectin in African American pregnant women may prognosticate
reduced protection against development of serious complications such as GDM.
Inflammatory mediators including endothelial adhesion molecules have been associated with
adverse pregnancy outcomes like preterm delivery [15,30,31]. More research is needed to confirm the
extent to which ethnic differences in adipokines and in their pattern contribute to adverse outcomes.
Likewise it would be important to examine links between maternal life style and diet to ethnic
variation in the adipokines, and to ethnic disparities during pregnancy.
4. Conclusions
In summary, we found ethnic differences in adiponectin and resistin in normal pregnant women.
African American women, in particular, had a higher prevalence of simultaneously decreased
adiponectin and increased resistin throughout pregnancy. Maternal resistin displayed a different
pattern from adiponectin in relation to anthropometry, blood pressure and glucose homeostasis.
Our data underscore the need for further research linking ethnic variation in adipokines and other
physiologic biomarkers with ethnic disparities during pregnancy.
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